Skip to content

Events & Presentations

UPCOMING EVENTS
DateEvent DetailsRemind Me
Feb 4, 2019
8:00 AM EST
Alexion Pharmaceuticals, Inc. Fourth Quarter 2018 Results

ARCHIVED EVENTS

Earnings Presentation
DateEvent Details
Jan 3, 2019
8:00 AM EST
Goldman Sachs 11th Annual Healthcare CEO Conference
Conference And Event Presentation
DateEvent DetailsRemind Me
Feb 4, 2019
8:00 AM EST
Alexion Pharmaceuticals, Inc. Fourth Quarter 2018 Results
Jan 8, 2019
8:00 AM PST
37th Annual J.P. Morgan Healthcare Conference Breakout Q&A Session
Jan 8, 2019
7:30 AM PST
37th Annual J.P. Morgan Healthcare Conference Presentation
Jan 3, 2019
8:00 AM EST
Goldman Sachs 11th Annual Healthcare CEO Conference
Nov 27, 2018
8:45 AM EST
Alexion to Present at the Evercore ISI Healthcare Conference
Nov 13, 2018
10:00 AM EST
Alexion to Present at Credit Suisse’s 27th Annual Healthcare Conference
Sep 26, 2018
8:00 AM EDT
Alexion to Acquire Syntimmune
Sep 24, 2018
8:30 AM EDT
Results of Phase 3 PREVENT Study of Soliris® in Patients with NMOSD.
Sep 14, 2018
11:05 AM EDT
Morgan Stanley’s 16th Annual Biotech Conference
Sep 6, 2018
8:15 AM EDT
Alexion to Present at Citi’s 13th Annual Biotech Conference
Jun 12, 2018
2:20 PM EDT
Alexion to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
May 16, 2018
5:20 PM EDT
Alexion to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
May 16, 2018
5:20 PM EDT
Alexion to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
Apr 11, 2018
8:30 AM EDT
Alexion to Acquire Wilson Therapeutics
Mar 15, 2018
8:30 AM EDT
Alexion Announces Positive Top-Line Results Showing Successful Phase 3 Clinical Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Mar 13, 2018
9:20 AM EDT
Alexion to Present at the Cowen and Company 38th Annual Health Care Conference